Market Place
Sourcing Support
All News #Library
Others
Avenacy To Attend 2026 DCAT Week
16 Mar 2026 //
BUSSINESSWIRE
Avenacy Outlines 2026 Priorities Ahead of 44th JPM Conference
08 Jan 2026 //
PHARMIWEB
Avenacy To Attend J.P. Morgan 44Th Annual Healthcare Conference
17 Dec 2025 //
BUSINESSWIRE
Avenacy To Join 2025 ASHP Midyear Clinical Meeting
03 Dec 2025 //
PHARMIWEB
Avenacy Showcases 2025 Successes, Seeks Partners At CPHI
22 Oct 2025 //
BUSINESSWIRE
Avenacy Secures Lending Deal with Texas Capital Bank
24 Jun 2025 //
BUSINESSWIRE
Avenacy to Attend 2025 DCAT Week
10 Mar 2025 //
BUSINESSWIRE
Avenacy Updates 2025 Goals Ahead of J.P. Morgan Conference
06 Jan 2025 //
BUSINESSWIRE
Avenacy to Attend J.P. Morgan 43rd Annual Healthcare Conference
16 Dec 2024 //
BUSINESSWIRE
Avenacy Announces Launch of Dexmedetomidine Injection, USP in US
18 Nov 2024 //
BUSINESSWIRE
Avenacy to Share Company’s Year One Progress at CPHI Milan 2024
23 Sep 2024 //
BUSINESSWIRE
Avenacy Launches Metoclopramide Injection In U.S. Market
16 Sep 2024 //
BUSINESSWIRE
Avenacy Announces Dr. Patrick Soon-Shiong As Major Investor And Co-Founder
20 Aug 2024 //
BUSINESSWIRE
Avenacy Launches Palonosetron Hydrochloride Injection In US Market
22 Jul 2024 //
BUSINESSWIRE
Avenacy Announces Launch Of Prochlorperazine Edisylate in the U.S. Market
26 Jun 2024 //
BUSINESSWIRE
Avenacy launches Tranexamic Acid Injection, USP in the U.S. market.
24 Jun 2024 //
BUSINESSWIRE
Avenacy Announces US Launch Of Magnesium Sulfate Injection
14 May 2024 //
BUSINESSWIRE
Avenacy Announces Launch of Furosemide for Injection in the U.S. Market
20 Mar 2024 //
BUSINESSWIRE
Avenacy Announces New Product Launches and Participation in DCAT Week 2024
18 Mar 2024 //
BUSINESSWIRE
Avenacy Announces Launch of Melphalan Hydrochloride for Injection
16 Jan 2024 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.